Menú

USR Terres de l’Ebre

RESPONSABLE
DE. 027 - Fotografía - (418) Alba Tor Roca
Alba Tor Roca
ator@idiapjgol.org
avatar_grups_recerca.png

Publicaciones

Machine Learning Approaches to Predict Major Adverse Cardiovascular Events in Atrial Fibrillation

P. MOLTÓ-BALADO, S. REVERTÉ-VILLARROYA, V. ALONSO-BARBERÁN, C. MONCLÚS-ARASA, M. BALADO-ALBIOL, J. CLUA-QUERALT and J. CLUA-ESPUNY
Technologies. 2024 Feb 1; . doi:10.3390/technologies12020013;

Ver más:
Delivering an innovative multi-disease screening and vaccination tool to high-risk migrant populations (ISMiHealth): Study protocol of a cluster randomised controlled trial

A. GRAELL, A. CRUZ, S. EVANGELIDOU, E. AYMAR, A. GONCALVES, E. COMA, C. MARTÍN, L. PERUCHA, A. PÉREZ, E. FERRER, J. CORONAS, J. VILLEGAS, N. ROMERO, M. GARCÍA, P. REQUENA, S. GODOY, M. VÁZQUEZ, C. AVIÑÓ and A. MÉNDEZ
TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2023 Nov 1;

Ver más:
Corrigendum to «Design and construct of an assessment tool for the handover of critical patient the in urgent care and emergency setting» [Int. Emerg. Nurs. 75 (2024) 101490]

R. TORTOSA-ALTED, M. BERENGUER-POBLET, S. REVERTÉ-VILLARROYA, J. FERNÁNDEZ-SÁEZ, F. ROCHE-CAMPO, M. ALCOVERRO-FANECA, R. FERRÉ-FELIPO, I. LLEIXÀ-BENET and E. MARTÍNEZ-SEGURA
International Emergency Nursing. 2024 Sep 1; . doi:10.1016/j.ienj.2024.101498; PMID:39129067

Ver más:
Epidemiology of infectious diseases in migrant populations from endemic or high-endemic countries: A multicentric primary care-based study in Spain

A. CRUZ, E. SEQUEIRA-AYMAR, A. GONÇALVES, L. CAMPS-VILA, M. MONCLÚS-GONZÁLEZ, E. REVUELTA-MUÑOZ, N. BUSQUET-SOLÉ, S. SARRIEGUI-DOMÍNGUEZ, A. CASELLAS, A. CUXART-GRAELL, M. LLORCA, C. AGUILAR-MARTÍN and A. REQUENA-MÉNDEZ
TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2024 Sep 1; . doi:10.1111/tmi.14036; PMID:39031944

Ver más:
The Predictive Potential of C-Peptide in Differentiating Type 1 Diabetes From Type 2 Diabetes in an Outpatient Population in Abu Dhabi

S. IQBAL, A. ABU JAYYAB, A. ALRASHDI, S. SHUJAUDDIN, J. CLUA-ESPUNY and S. REVERTÉ-VILLARROYA
CLINICAL THERAPEUTICS. 2024 Sep 1; . doi:10.1016/j.clinthera.2024.07.002; PMID:39117487

Ver más: